web analytics

Report from the Annual General Meeting of EQL Pharma AB (publ) on August 22nd, 2019

At EQL Pharma’s Annual General Meeting, which was held today in Lund, August 22nd, 2019, the following decisions were made:
Adoption of the balance sheet and income statement, disposition regarding the Company’s results

The annual general meeting resolved to adopt the balance sheet and income statement and the consolidated balance sheet and income statement for the financial year 2018-04-01 – 2019-03-31. The annual general meeting also resolved that no dividends shall be paid for the financial year 2018/2019.

Discharge from liability for the Board of Directors and the Managing Director

Source: Report from the Annual General Meeting of EQL Pharma AB (publ) on August 22nd, 2019

Leave a Comment

This site uses Akismet to reduce spam. Learn how your comment data is processed.